How and Why to Involve Patients in Drug Development: Perspectives from the Pharmaceutical Industry, Regulatory Authorities and Patient Organizations

Marianne Botoft Hansen, Lotte Stig Nørgaard, Christine Erikstrup Hallgreen

3 Citations (Scopus)

Fingerprint

Dive into the research topics of 'How and Why to Involve Patients in Drug Development: Perspectives from the Pharmaceutical Industry, Regulatory Authorities and Patient Organizations'. Together they form a unique fingerprint.

Medicine & Life Sciences